In summary, we have demonstrated that T-bet activity during a chronic viral infection can impede antiviral immune control by driving the development of highly differentiated TH1-like cells that express genes encoding inhibitory molecules, including IL-10 and Arg1. This evidence concerns the gene ARG1 and viral infectious disease.